1.Factors Affecting Invasive Management after Unplanned Extubation in an Intensive Care Unit.
A Lan LEE ; Chi Ryang CHUNG ; Jeong Hoon YANG ; Kyeongman JEON ; Chi Min PARK ; Gee Young SUH
Korean Journal of Critical Care Medicine 2015;30(3):164-170
BACKGROUND: Unplanned extubation (UE) of patients requiring mechanical ventilation in an intensive care unit (ICU) is associated with poor outcomes for patients and organizations. This study was conducted to assess the clinical features of patients who experienced UE and to determine the risk factors affecting reintubation after UE in an ICU. METHODS: Among all adult patients admitted to the ICU in our institution who required mechanical ventilation between January 2011 and December 2013, those in whom UE was noted were included in the study. Data were categorized according to noninvasive or invasive management after UE. RESULTS: The rate of UE was 0.78% (the number of UEs per 100 days of mechanical ventilation). The incidence of self-extubation was 97.2%, while extubation was accidental in the remaining patients. Two cases of cardiac arrest combined with respiratory arrest after UE were noted. Of the 214 incidents, 54.7% required invasive management after UE. Long duration of mechanical ventilation (odds ratio [OR] 1.52; 95% confidence interval [CI] 1.32-1.75; p = 0.000) and high ICU mortality (OR 4.39; 95% CI 1.33-14.50; p = 0.015) showed the most significant association with invasive management after UE. In multivariate analysis, younger age (OR 0.96; 95% CI 0.93-0.99; p = 0.005), medical patients (OR 4.36; 95% CI 1.95-9.75; p = 0.000), use of sedative medication (OR 4.95; 95% CI 1.97-12.41; p = 0.001), large amount of secretion (OR 2.66; 95% CI 1.01-7.02; p = 0.049), and low PaO2/FiO2 ratio (OR 0.99; 95% CI 0.98-0.99; p = 0.000) were independent risk factors of invasive management after UE. CONCLUSIONS: To prevent unfavorable clinical outcomes, close attention and proper ventilatory support are required for patients with risk factors who require invasive management after UE.
Adult
;
Heart Arrest
;
Humans
;
Incidence
;
Intensive Care Units*
;
Critical Care*
;
Mortality
;
Multivariate Analysis
;
Respiration, Artificial
;
Risk Factors
2.Subclavian Artery Laceration Caused by Pigtail Catheter Removal in a Patient with Pneumothorax.
Hyo Jin KIM ; Yang Hyun CHO ; Gee Young SUH ; Jeong Hoon YANG ; Kyeongman JEON
Korean Journal of Critical Care Medicine 2015;30(2):119-122
We report a case of subclavian artery laceration caused by the removal of a pigtail pleural drainage catheter in a patient with a pneumothorax. The patient was successfully resuscitated through diagnostic angiography with subsequent balloon occlusion and primary repair of the injured subclavian artery. Although pigtail drainage of a pneumothorax is known to be safe and effective, proper insertion and removal techniques should be emphasized to reduce the risk of complications.
Angiography
;
Balloon Occlusion
;
Catheters*
;
Drainage
;
Hemothorax
;
Humans
;
Lacerations*
;
Pneumothorax*
;
Subclavian Artery*
;
Thoracostomy
3.Refractory Septic Shock Treated with Nephrectomy under the Support of Extracorporeal Membrane Oxygenation.
Young Kun LEE ; Jeong Am RYU ; Jeong Hoon YANG ; Chi Min PARK ; Gee Young SUH ; Kyeongman JEON ; Chi Ryang CHUNG
Korean Journal of Critical Care Medicine 2015;30(3):176-179
Conventional medical therapies have not been very successful in treating adults with refractory septic shock. The effects of direct hemoperfusion using polymyxin B and veno-arterial extracorporeal membrane oxygenation (ECMO) for refractory septic shock remain uncertain. A 66-year-old man was admitted to the emergency department and suffered from sepsis-induced hemodynamic collapse. For hemodynamic improvement, we performed direct hemoperfusion using polymyxin B. Computed tomography scan of this patient revealed emphysematous pyelonephritis (EPN), for which he underwent emergent nephrectomy with veno-arterial ECMO support. To the best of our knowledge, this is the first report of successful treatment of EPN with refractory septic shock using polymyxin B hemoperfusion and nephrectomy under the support of ECMO.
Adult
;
Aged
;
Emergency Service, Hospital
;
Endotoxins
;
Extracorporeal Membrane Oxygenation*
;
Hemodynamics
;
Hemoperfusion
;
Humans
;
Nephrectomy*
;
Polymyxin B
;
Pyelonephritis
;
Shock, Septic*
4.Ventilator-Associated Pneumonia.
Tuberculosis and Respiratory Diseases 2011;70(3):191-198
Ventilator-associated pneumonia (VAP) is the most frequent nosocomial infection in the intensive care unit (ICU), with an incidence ranging from 8% to 38%. Patients who acquire VAP have higher mortality rates and longer ICU and hospital stays. Because there are other potential causes of fever, leukocytosis, and pulmonary infiltrates, clinical diagnosis of VAP is overly sensitive. The only alternative approach to the clinical diagnosis of VAP is the Clinical Pulmonary Infection Score (CPIS). Employing quantitative cultures of respiratory secretions in the diagnosis of VAP leads to less antibiotic use and probably to lower mortality. With respect to microbiologic diagnosis, however, it is not clear that the use of invasive sampling using bronchoscopy is associated with better outcomes. Delayed administration of antibiotic therapy is associated with an increased mortality, and inadequate antibiotic therapy is also associated with higher mortality. Therefore, prompt initiation of adequate antibiotic therapy is a cornerstone of the treatment of VAP. The initial antibiotic therapy should be based on the most common organisms in each hospital and the most likely pathogens for that specific patient. When final cultures and susceptibilities are available, de-escalation to less broad spectrum antibiotics should be done. Since clinical improvement usually takes 2 to 3 days, clinical responses to the initial empirical therapy should be evaluated by day 3. A short course of antibiotic therapy appears to be equivalent to a traditional course of more than 14 days, except when treating non-fermenting gram-negative organisms. If patients receive initially adequate antibiotic therapy, efforts should be made to shorten the duration of therapy to as short as 7 days, provided that the etiologic pathogen is not a non-fermenting gram-negative organism.
Anti-Bacterial Agents
;
Bronchoscopy
;
Cross Infection
;
Fever
;
Humans
;
Incidence
;
Intensive Care Units
;
Length of Stay
;
Leukocytosis
;
Pneumonia, Ventilator-Associated
5.Pharmacotherapy for Acute Respiratory Distress Syndrome: Limited Success to Date.
Tuberculosis and Respiratory Diseases 2017;80(3):311-312
No abstract available.
Drug Therapy*
;
Respiratory Distress Syndrome, Adult*
6.The Control of Tuberculosis in Korean Military Personnel.
Sei Won LEE ; Kyeongman JEON ; Chang Min CHOI
Tuberculosis and Respiratory Diseases 2008;65(6):453-456
No abstract available.
Humans
;
Military Personnel
;
Tuberculosis
7.Disseminated Gastrointestinal Mucormycosis in Immunocompromised Disease.
Tae Sun HA ; Chi Min PARK ; Jeong Hoon YANG ; Yang Hyun CHO ; Chi Ryang CHUNG ; Kyeongman JEON ; Gee Young SUH
Korean Journal of Critical Care Medicine 2015;30(4):323-328
Mucormycosis is an uncommon opportunistic fungal infection mostly affecting immunocompromised patients and gastrointestinal mucormycosis is a rare and life-threatening. We describe a 31-year-old man with a history of idiopathic cyclic neutropenia who developed perforations of the stomach and intestine and intra-abdominal bleeding due to disseminated gastrointestinal mucormycosis after the initial operation.
Adult
;
Gastrointestinal Tract
;
Hemorrhage
;
Humans
;
Immunocompromised Host
;
Intestines
;
Mucormycosis*
;
Neutropenia
;
Stomach
8.Expanding Use of the ProVent Score
Tuberculosis and Respiratory Diseases 2019;82(2):173-174
No abstract available.
10.Successful Treatment with Empirical Erlotinib in a Patient with Respiratory Failure Caused by Extensive Lung Adenocarcinoma.
Suk Hyeon JEONG ; Sang Won UM ; Hyun LEE ; Kyeongman JEON ; Kyung Jong LEE ; Gee Young SUH ; Man Pyo CHUNG ; Hojoong KIM ; O Jung KWON ; Yoon La CHOI
Korean Journal of Critical Care Medicine 2016;31(1):44-48
We herein describe a 70-year-old woman who presented with respiratory failure due to extensive lung adenocarcinoma. Despite advanced disease, care in the intensive care unit with ventilator support was performed because she was a newly diagnosed patient and was considered to have the potential to recover after cancer treatment. Because prompt control of the cancer was needed to treat the respiratory failure, empirical treatment with an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor was initiated before confirmation of EGFR-mutant adenocarcinoma, and the patient was successfully treated. Later, EGFR-mutant adenocarcinoma was confirmed.
Adenocarcinoma*
;
Aged
;
Female
;
Humans
;
Intensive Care Units
;
Lung*
;
Protein-Tyrosine Kinases
;
Receptor, Epidermal Growth Factor
;
Respiration, Artificial
;
Respiratory Insufficiency*
;
Ventilators, Mechanical
;
Erlotinib Hydrochloride